摘要
采用毛细管气相色谱-电子捕获法测定18名键康男性志愿者多剂量交叉口服40mg5-单硝酸异山梨醇酯缓释制剂(国产片和进口胶囊)后的血药浓度变化情况。单剂量研究结果表明:片与胶囊的ka分别为0.2479、0.2504h-1,ke为0.1403、0.1379h-1,tmax为5.35、5.36h,Cmax为377.09、351.98ng/ml;缓释片的相对生物利用度为106.28%。多剂量研究结果表明片与胶囊的波动系数分别为1.97与1.86。
The isosorbide5mononitrate ( 1 ) concentration in plasma was determined by CGCECD method following an oral multidose of domestic 1 sustained release tablets and imported 1 sustained release capsules given to 18 healthy male volunteers in an open randomized crossover test.The monodose test showed that k\-a was 0.2479 and 0.2504 h\+\{-1\},k\-e 0.1403 and 0.1379 h\+\{-1\},tmax 5.35 and 5.36 h,Cmax 377.09 and 351.98 ng/ml respectively.The relative bioavailability of 1 sustained release tablets was 106.28%.And the multidose test showed that the fluctuation index of the tablets and the capsules was 1.97 and 1.86 respectively.
出处
《中国医药工业杂志》
CAS
CSCD
北大核心
1999年第6期262-264,共3页
Chinese Journal of Pharmaceuticals
关键词
单硝酸异山梨酯
片剂
药动学
相对生物利用度
isosorbide 5mononitrate,CGCECD,pharmacokinetics,relative bioavailability